Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

BOTTICELLI, A INQUIETUDE e A BELEZA - Menarini apresenta em Florença a sua mais recente monografia de arte, dedicada ao símbolo do Renascimento italiano.
  • Latin America - español
  • USA - Deutsch
  • USA - español
  • USA - Français
  • USA - English
  • India - English
  • Italia - Italiano

MENARINI Group Logo

News provided by

Menarini Industrie Farmaceutiche Riunite

May 16, 2023, 06:59 ET

Share this article

Share toX

Share this article

Share toX

FLORENÇA, Itália, 16 de maio de 2023 /PRNewswire/ -- Artista de grande sucesso, intérprete atento da cultura do seu tempo e criador de obras extraordinariamente relevantes, Sandro Botticelli foi um mestre da beleza. Com as suas Vénus estabeleceu, sem o saber, um cânone de perfeição que reflete fielmente os padrões da atualidade.  No entanto, Botticelli era uma figura misteriosa e inquieta: apesar da sua reputação intemporal, as suas pinturas ainda ocultam mistérios que são difíceis de revelar.  Passados sessenta anos, Sandro Botticelli regressa à série de arte do Grupo Menarini com uma monografia inédita apresentada na Sala Apolo do Palazzo Pucci em Florença, na presença da autora Cristina Acidini, ex-superintendente dos museus de arte de Florença e atual presidente da Ópera di Santa Croce e de outras prestigiadas instituições florentinas.

Continue Reading
Nicola Armentano (City of Florence Councillor), Lucia Aleotti (Menarini Group Shareholder and Board Member), Cristina Acidini (Author of the Botticelli art monograph), Eric Cornut (Menarini Group Chairman), Eugenio Giani (President of Region of Tuscany); Elcin Barker Ergun (Menarini Group CEO), Alberto Giovanni Aleotti (Menarini Group Shareholder and Board Member) and Carlo Colombini (Menarini Group Board Member)
Nicola Armentano (City of Florence Councillor), Lucia Aleotti (Menarini Group Shareholder and Board Member), Cristina Acidini (Author of the Botticelli art monograph), Eric Cornut (Menarini Group Chairman), Eugenio Giani (President of Region of Tuscany); Elcin Barker Ergun (Menarini Group CEO), Alberto Giovanni Aleotti (Menarini Group Shareholder and Board Member) and Carlo Colombini (Menarini Group Board Member)
Presentation of the Menarini art volume dedicated to Botticelli
Presentation of the Menarini art volume dedicated to Botticelli

A monografia transporta-nos para a Florença da segunda metade do século XV e para a fábrica de tingimento de Mariano Filipepi, o pai de Botticelli. Foi lá que o jovem Sandro, fascinado pelas cores utilizadas na oficina da família, entrou pela primeira vez em contacto com o estudo das artes.  As poucas fontes coevas disponíveis descreviam o artista como um homem inclinado para a ironia, sarcasmo e escárnio, refletindo o espírito de Florença da época.  A sua alma era atormentada por um temperamento inquieto; recusou-se categoricamente a casar, mas declarou um amor eterno por Florença, uma cidade que nunca abandonou, com exceção de algumas pequenas viagens.  Com a sensibilidade apurada do ser humano e artista, registou as mudanças que aconteceram na sua cidade, desde os triunfos carnavalescos de Lorenzo de Medici às procissões penitenciais de Savonarola.  Enquanto artista, teve a capacidade única de se adaptar às mudanças da sua época, pintando figuras atormentadas com cores mais escuras, como o Lamento sobre Cristo Morto e a Santíssima Trindade (Holy Trinity) (Pala delle Convertite), muito longe da harmonia e graça do Nascimento de Vénus (Birth of Venus) e Primavera (Spring).  Estas duas últimas obras, com as suas inúmeras variações e reinvenções, ajudaram a tornar Botticelli um artista extremamente popular, cuja relevância permanece como tema de estudo moderno até hoje.

Assim, há muitas controvérsias sobre a cronologia e interpretação de muitas das pinturas de Botticelli, incluindo as mais famosas. Na verdade, restaurações e sofisticadas investigações diagnósticas trazem constantemente à superfície novos elementos que geram ideias para debate entre especialistas do setor.

"Este extraordinário artista regressa à série Menarini com uma segunda monografia que tem em conta as inovações que surgiram nos últimos sessenta anos, graças à descoberta de novos documentos e suas interpretações, especialmente os relacionados com as suas pinturas mais evocativas e misteriosas.  Além disso, as investigações científicas relacionadas com a restauração de muitas das obras de Botticelli enriqueceram o nosso conhecimento do seu estilo de pintura refinado e versátil", declarou Cristina Acidini.  "Botticelli era, de facto, um dos mais autênticos intérpretes da cultura da sua época, refletindo as profundas mudanças na sociedade florentina onde viveu, dominado primeiro por Lorenzo o Magnífico, num período de grande florescimento cultural, depois por Girolamo Savonarola, durante um período de perturbado reformismo religioso.  Por esta razão, tornou-se o "símbolo" do Renascimento (Renaissance), com todo o seu esplendor e inquietude". 

O volume de arte de Botticelli enriquece a prestigiada série de arte do Menarini Group, criado em 1956 para celebrar a beleza da Itália através dos grandesmestres da pintura italiana.

"A coleção de arte Menarini tem como objetivo promover grandes artistas italianos e partilhá-los até com a geração mais jovem", dizem Lucia e Alberto Giovanni Aleotti, acionistas e membros do Conselho de Administração da Menarini. "Descobrir a inquietude e maravilha nas pinturas mais notáveis de Botticelli demonstra o quão próximo o artista estava do sentimento contemporâneo de hoje".

Ao longo dos anos, a vocação artística do Menarini Group cresceu e evoluiu com o projeto multimédia "Menarini Pills of Art". Tratam-se de pequenos vídeos nos quais os especialistas revelam episódios e curiosidades sobre muitos dos trabalhos apresentados nos volumes Menarini.  Até agora, cerca de 700 vídeos foram publicados, com um total de dezenas de milhões de visualizações. Estão disponíveis em 8 idiomas no canal Menarini YouTube, que é atualizado mensalmente com novos conteúdos. Vídeos sobre algumas das obras mais famosas de Botticelli foram publicados recentemente juntamente com vídeos sobre A Adoração dos Magos (Magi), de Leonardo da Vinci, Madonna delle Cave, de Mantegna, e Baco, de Caravaggio.

Os Menarini Pills of Art estão disponíveis no link: https://www.menarini.com/it-it/news/menarini-pills-of-art

O Menarini Pharmaceutical Group, com sede em Florença, está presente em 140 países em todo o mundo, com um volume de negócios de 4155€ milhões e mais de 17000 funcionários. Com 9 centros de Investigação e Desenvolvimento, os produtos Menarini estão presentes nas áreas de tratamento mais importantes, incluindo cardiologia, oncologia, gastroenterologia, pneumologia, doenças infecciosas, diabetes e produtos anti-inflamatórios/analgésicos. A produção farmacêutica é levada a cabo nas 18 fábricas do Grupo, localizadas em Itália e no estrangeiro, que produzem mais de 577 milhões de pacotes de produtos por ano e os distribuem pelos cinco continentes. A produção farmacêutica da Menarini, em consonância com os mais altos padrões de qualidade, contribui continuamente para a saúde dos pacientes em todo o mundo. Para mais informações, por favor visite www.menarini.com

Fotografia - https://mma.prnewswire.com/media/2076875/Menarini_group.jpg
Fotografia - https://mma.prnewswire.com/media/2076874/Menarini_presentation.jpg
Logótipo - https://mma.prnewswire.com/media/1958938/4035543/MENARINI_GROUP_Logo.jpg

FONTE Menarini Industrie Farmaceutiche Riunite

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Menarini Group anuncia nuevos datos sobre ELZONRIS® (tagraxofusp-erzs)

Menarini Group anuncia nuevos datos sobre ELZONRIS® (tagraxofusp-erzs)

Menarini Group ("Menarini"), una compañía farmacéutica y de diagnóstico internacional líder, y Stemline Therapeutics, Inc. ("Stemline"), una filial...

Les Volpi Rosse Menarini : Les « dix fantastiques » sont prêts pour la saison 2025 - 2026

Les Volpi Rosse Menarini : Les « dix fantastiques » sont prêts pour la saison 2025 - 2026

Dix talents internationaux, d'âge et d'expérience différents, mais unis par le désir de faire la différence, tant en Italie qu'en Europe. Après le...

More Releases From This Source

Explore

Entertainment

Entertainment

Art

Art

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.